Delta 9 Cannabis Inc. engages in the production and sale of medical cannabis products. Its products include strains, clones, and LP starting materials. The company also operates a medical clinic that provides physician consultation services to patients seeking a medical recommendation. In addition, the company offers integra boost for preserving the smell of the flowers. Delta 9 Cannabis Inc. is based in Vancouver, Canada.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$2.60 million
Profitability
Miscellaneous
Employees79
OptionableOptionable
Delta 9 Cannabis (CVE:NINE) Frequently Asked Questions
What is Delta 9 Cannabis' stock symbol?
Delta 9 Cannabis trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NINE."
Has Delta 9 Cannabis been receiving favorable news coverage?
Media headlines about NINE stock have trended positive this week, according to InfoTrie. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Delta 9 Cannabis earned a daily sentiment score of 2.3 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next few days.
Who are some of Delta 9 Cannabis' key competitors?
Some companies that are related to Delta 9 Cannabis include CV Sciences (CVSI), HLS Therapeutics (HLS), Depomed (ASRT), ICC Labs (ICC), Zomedica Pharmaceuticals (ZOM), WeedMD (WMD), Biosyent (RX), Probiotec (PBP), Invion (IVX), Viridium Pacific Group (VIR), MMJ Group (MMJ), Indiva (NDVA), Cipher Pharmaceuticals (CPH), MGC Pharmaceuticals (MXC) and ESSA Pharma (EPI).
Who are Delta 9 Cannabis' key executives?
Delta 9 Cannabis' management team includes the folowing people:
- Mr. John William Arbuthnot IV, CEO & Director (Age 29)
- Mr. John William Arbuthnot III, Chairman & Pres (Age 65)
- Mr. Jim Lawson, Interim CFO & Controller
- Mr. Gary Symons, Director of Communications
How do I buy shares of Delta 9 Cannabis?
Shares of NINE and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Delta 9 Cannabis' stock price today?
One share of NINE stock can currently be purchased for approximately C$1.49.
How big of a company is Delta 9 Cannabis?
Delta 9 Cannabis has a market capitalization of C$127.61 million and generates C$2.60 million in revenue each year. Delta 9 Cannabis employs 79 workers across the globe.
What is Delta 9 Cannabis' official website?
MarketBeat Community Rating for Delta 9 Cannabis (CVE NINE)
MarketBeat's community ratings are surveys of what our community members think about Delta 9 Cannabis and other stocks. Vote "Outperform" if you believe NINE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NINE will underperform the S&P 500 over the long term. You may vote once every thirty days.
